Ssri Discontinuation Syndrome (Paperback)

, ,
High Quality Content by WIKIPEDIA articles! SSRI discontinuation syndrome (also known as SSRI withdrawal syndrome or SSRI cessation syndrome) is a cluster of symptoms syndrome that can occur following the interruption, dose reduction, or discontinuation of SSRI (selective serotonin reuptake inhibitor) or SNRI antidepressant medications. The condition often begins between 24 hours to 10 days after reduction in dosage or complete discontinuation, depending on the elimination half-life of the drug and the patient's metabolism. The prescribing labels of some SSRIs note the possibility of "intolerable" discontinuation reactions. Some patients have extreme difficulty discontinuing use of SSRI drugs. The existence of the syndrome is somewhat controversial, however, there are double-blind placebo-controlled studies that demonstrate statistically significant results for the discontinuation of an SSRI used in monotherapy.

R1,289

Or split into 4x interest-free payments of 25% on orders over R50
Learn more

Discovery Miles12890
Mobicred@R121pm x 12* Mobicred Info
Free Delivery
Delivery AdviceOut of stock

Toggle WishListAdd to wish list
Review this Item

Product Description

High Quality Content by WIKIPEDIA articles! SSRI discontinuation syndrome (also known as SSRI withdrawal syndrome or SSRI cessation syndrome) is a cluster of symptoms syndrome that can occur following the interruption, dose reduction, or discontinuation of SSRI (selective serotonin reuptake inhibitor) or SNRI antidepressant medications. The condition often begins between 24 hours to 10 days after reduction in dosage or complete discontinuation, depending on the elimination half-life of the drug and the patient's metabolism. The prescribing labels of some SSRIs note the possibility of "intolerable" discontinuation reactions. Some patients have extreme difficulty discontinuing use of SSRI drugs. The existence of the syndrome is somewhat controversial, however, there are double-blind placebo-controlled studies that demonstrate statistically significant results for the discontinuation of an SSRI used in monotherapy.

Customer Reviews

No reviews or ratings yet - be the first to create one!

Product Details

General

Imprint

Betascript Publishing

Country of origin

Germany

Release date

May 2010

Availability

Supplier out of stock. If you add this item to your wish list we will let you know when it becomes available.

First published

May 2010

Authors

, ,

Dimensions

152 x 229 x 10mm (L x W x T)

Format

Paperback - Trade

Pages

166

ISBN-13

978-6130458140

Barcode

9786130458140

Categories

LSN

6130458142



Trending On Loot